Doximity (NYSE:DOCS) Cut to “Hold” at Wall Street Zen

Wall Street Zen cut shares of Doximity (NYSE:DOCS) from a buy rating to a hold rating in a research note released on Saturday morning.

Several other research firms have also issued reports on DOCS. Barclays upgraded Doximity to a “strong-buy” rating in a research note on Monday, December 8th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Doximity in a report on Wednesday, December 24th. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy”.

Doximity Stock Performance

NYSE DOCS opened at $43.90 on Friday. Doximity has a 1-year low of $42.66 and a 1-year high of $85.21. The company has a market cap of $8.27 billion, a price-to-earnings ratio of 34.84, a P/E/G ratio of 2.03 and a beta of 1.39.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.